Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Jan 4;168(3):703–712. doi: 10.1007/s10549-017-4638-1

Table 2.

Performance of polygenic risk scores by family history of breast cancer, and joint model of polygenic risk score and family history of breast cancer

Model # of SNPs Odds ratio source AUC (95% CI) AUC (95% CI)*
FH + PRS (N=3186)

With FH (N=439) No FH (N=2747)
1 75 WHI [17] 0.554 (0.497–0.610) 0.516 (0.494–0.537) 0.552 (0.532–0.572)

2 75 AABC [13,12] 0.558 (0.502–0.613) 0.512 (0.490–0.533) 0.549 (0.529–0.569)

3 77 BCAC [6] 0.558 (0.503–0.613) 0.503 (0.481–0.525) 0.543 (0.522–0.563)

4 93 BCAC [6,2] 0.554 (0.499–0.609) 0.515 (0.493–0.537) 0.552 (0.532–0.572)

5 45 WHI [17] 0.585 (0.530–0.640) 0.519 (0.498–0.541) 0.555 (0.535–0.575)
6 AABC [13,12] 0.570 (0.514–0.626) 0.514 (0.492–0.536) 0.551 (0.531–0.571)

7 34 WHI [17] 0.586 (0.532–0.640) 0.521 (0.500–0.543) 0.557 (0.537–0.577)
8 AABC [13,12] 0.568 (0.513–0.623) 0.515 (0.493–0.536) 0.551 (0.531–0.571)
9 BCAC [6,2] 0.557 (0.501–0.612) 0.520 (0.498–0.541) 0.555 (0.535–0.575)
*

ROC analysis of joint model of family history and polygenic risk score

P<0.05 in the heterogeneity test comparing AUCs in subjects with or without family history of breast cancer.

Abbreviation: WHI, Women’s Health Initiative (African American); AABC, African-American Breast Cancer GWAS study; BCAC, Breast Cancer Association Consortium; ROOT, GWAS of Breast Cancer in the African Diaspora; AUC, area under the receiver operating curve; CI, confidence interval; FH, family history of breast cancer